A review of telmisartan in the treatment of hypertension: blood pressure control in the early morning hours.

Vasc Health Risk Manag · 2006 · PMC1993985 · PMID 17326326

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a notable trendno p-value reported

It was also observed in one of the two studies that there was a notable trend for greater blood pressure reduction in the telmisartan group compared with the valsartan group in latter part of the dosing interval on the day on which a dose was missed ( White et al 2004 ).

also in 2,380 other papers

highly significantno p-value reported

Telmisartan-based treatment produced highly significant reductions in the daytime and night-time mean blood pressures.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.